Elevance Health Inc. (NYSE: ELV) reported Q3 EPS of $6.99, $2.29 better than the analyst estimate of $4.70. Revenue for the quarter came in at $50.4 billion versus the consensus estimate of $49.32 billion.

GUIDANCE:

Elevance Health Inc. sees FY2026 EPS of $29.00, versus the consensus of $27.24.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.